{"meta":{"status":200,"messages":[],"pagination":{"max":1,"offset":0,"count":1,"total":1,"pageNum":1,"totalPages":1,"sort":null,"currentUrl":"https://api.digitalmedia.hhs.gov/api/v2/resources/media.json?offset=0&max=1&ignoreHiddenMedia=1&format=json&id=5334&newUrlBase=http://www.cdc.gov/lyme/healthcare","nextUrl":null,"previousUrl":null}},"results":[{"content":"\n
\n

Lyme Disease Continuing Education

\n
\n
\n
\n
\n
\n
\n

What to know

\n
\n
\n

These continuing education activities serve as a valuable resource for primary care clinicians, public health professionals, pharmacists, and health educators who encounter patients with Lyme disease. Free Continuing Education credits are available.

\n
\n
\n
\n
\n \"Illustration \n
\n
\n
\n
\n
\n
\n
\n \n \n

Lyme disease training modules

\n

Module 1: Introduction to tickborne diseases and disease prevention (WB4984)

\n

This module highlights the following topics:

\n
    \n
  • Lyme disease transmission
    • \n
  • Lyme disease geographic distribution
    • \n
  • Care of a patient presenting with a tick bite
    • \n
  • Appropriate use of post-exposure prophylaxis for Lyme disease after tick bite
    • \n
  • Patient education about tick bite prevention
    • \n
\n

Learn more and register

\n

Module 2: Lyme disease clinical overview (WB4985)

\n

This module highlights the following topics:

\n
    \n
  • Early localized and disseminated manifestations
    • \n
  • Differentiating erythema migrans from other similar skin conditions
    • \n
  • Recognizing clinical presentations that might suggest tickborne disease co-infections
    • \n
\n

Learn more and register

\n

Module 3: Lyme disease testing and diagnosis (WB4986)

\n

This module highlights the following topics:

\n
    \n
  • How to select validated tests
    • \n
  • Why there is currently no \"test of cure\"
    • \n
  • How pretest probability and disease stage inform whether to test for Lyme disease
    • \n
  • The significance of the seroconversion window period
    • \n
  • Why testing for Lyme disease may not be clinically helpful for patients with erythema migrans
    • \n
\n

Learn more and register

\n

Module 4: Lyme disease treatment and management (WB4987)

\n

This module highlights the following topics:

\n
    \n
  • Treatment options for erythema migrans
    • \n
  • Clinical management of Lyme carditis
    • \n
  • Clinical management of Lyme arthritis
    • \n
  • Clinical management of neurologic Lyme disease
    • \n
  • Care of patients with persistent symptoms attributed to Lyme disease
    • \n
\n

Learn more and register

\n
\n
\n \n \n

Clinician Outreach and Communication Activity (COCA) webinar

\n

This webinar provides healthcare providers and their patients with updated information in Lyme disease epidemiology, diagnosis, treatment, and prevention.

\n

September 2024: New Clinical Tools and Resources to Support Patients with Prolonged Symptoms and Concerns about Lyme Disease (WC4520R-091924)

\n

Watch Webinar on clinical approaches, tools, and resources for healthcare providers caring for patients with prolonged symptoms and concerns about Lyme disease.

\n


\n
\n
\n
\n \n \n
\n
\n
\n \n
\n
\n
\n Sources \n Print \n Share \n
\n \n \n \n \n
\n
\n
\n
\n Facebook \n LinkedIn \n Twitter \n Syndicate \n
\n
\n
\n
\n
\n Content Source: \n
\n National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) \n
\n
\n
\n
\n
\n
\n \n
Syndicated Content Details:
Source URL: http://www.cdc.gov/lyme/healthcare/clinician_twotier.html
Source Agency: Centers for Disease Control and Prevention (CDC)
Captured Date: 2016-05-23 21:57:05.0
","description":"Information on Lyme disease. Provided by the U.S. Centers for Disease Control and Prevention.","id":5334,"mediaType":"Html","name":"Two-tiered Testing Decision Tree for Lyme Disease","sourceUrl":"http://www.cdc.gov/lyme/healthcare/clinician_twotier.html"}]}